Cargando…
Medicinal Use of Testosterone and Related Steroids Revisited
Testosterone derivatives and related compounds (such as anabolic-androgenic steroids—AAS) are frequently misused by athletes (both professional and amateur) wishing to promote muscle development and strength or to cover AAS misuse. Even though these agents are vastly regarded as abusive material, th...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919692/ https://www.ncbi.nlm.nih.gov/pubmed/33672087 http://dx.doi.org/10.3390/molecules26041032 |
_version_ | 1783658174541201408 |
---|---|
author | Tauchen, Jan Jurášek, Michal Huml, Lukáš Rimpelová, Silvie |
author_facet | Tauchen, Jan Jurášek, Michal Huml, Lukáš Rimpelová, Silvie |
author_sort | Tauchen, Jan |
collection | PubMed |
description | Testosterone derivatives and related compounds (such as anabolic-androgenic steroids—AAS) are frequently misused by athletes (both professional and amateur) wishing to promote muscle development and strength or to cover AAS misuse. Even though these agents are vastly regarded as abusive material, they have important pharmacological activities that cannot be easily replaced by other drugs and have therapeutic potential in a range of conditions (e.g., wasting syndromes, severe burns, muscle and bone injuries, anemia, hereditary angioedema). Testosterone and related steroids have been in some countries treated as controlled substances, which may affect the availability of these agents for patients who need them for therapeutic reasons in a given country. Although these agents are currently regarded as rather older generation drugs and their use may lead to serious side-effects, they still have medicinal value as androgenic, anabolic, and even anti-androgenic agents. This review summarizes and revisits the medicinal use of compounds based on the structure and biological activity of testosterone, with examples of specific compounds. Additionally, some of the newer androgenic-anabolic compounds are discussed such as selective androgen receptor modulators, the efficacy/adverse-effect profiles of which have not been sufficiently established and which may pose a greater risk than conventional androgenic-anabolic agents. |
format | Online Article Text |
id | pubmed-7919692 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79196922021-03-02 Medicinal Use of Testosterone and Related Steroids Revisited Tauchen, Jan Jurášek, Michal Huml, Lukáš Rimpelová, Silvie Molecules Review Testosterone derivatives and related compounds (such as anabolic-androgenic steroids—AAS) are frequently misused by athletes (both professional and amateur) wishing to promote muscle development and strength or to cover AAS misuse. Even though these agents are vastly regarded as abusive material, they have important pharmacological activities that cannot be easily replaced by other drugs and have therapeutic potential in a range of conditions (e.g., wasting syndromes, severe burns, muscle and bone injuries, anemia, hereditary angioedema). Testosterone and related steroids have been in some countries treated as controlled substances, which may affect the availability of these agents for patients who need them for therapeutic reasons in a given country. Although these agents are currently regarded as rather older generation drugs and their use may lead to serious side-effects, they still have medicinal value as androgenic, anabolic, and even anti-androgenic agents. This review summarizes and revisits the medicinal use of compounds based on the structure and biological activity of testosterone, with examples of specific compounds. Additionally, some of the newer androgenic-anabolic compounds are discussed such as selective androgen receptor modulators, the efficacy/adverse-effect profiles of which have not been sufficiently established and which may pose a greater risk than conventional androgenic-anabolic agents. MDPI 2021-02-15 /pmc/articles/PMC7919692/ /pubmed/33672087 http://dx.doi.org/10.3390/molecules26041032 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Tauchen, Jan Jurášek, Michal Huml, Lukáš Rimpelová, Silvie Medicinal Use of Testosterone and Related Steroids Revisited |
title | Medicinal Use of Testosterone and Related Steroids Revisited |
title_full | Medicinal Use of Testosterone and Related Steroids Revisited |
title_fullStr | Medicinal Use of Testosterone and Related Steroids Revisited |
title_full_unstemmed | Medicinal Use of Testosterone and Related Steroids Revisited |
title_short | Medicinal Use of Testosterone and Related Steroids Revisited |
title_sort | medicinal use of testosterone and related steroids revisited |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919692/ https://www.ncbi.nlm.nih.gov/pubmed/33672087 http://dx.doi.org/10.3390/molecules26041032 |
work_keys_str_mv | AT tauchenjan medicinaluseoftestosteroneandrelatedsteroidsrevisited AT jurasekmichal medicinaluseoftestosteroneandrelatedsteroidsrevisited AT humllukas medicinaluseoftestosteroneandrelatedsteroidsrevisited AT rimpelovasilvie medicinaluseoftestosteroneandrelatedsteroidsrevisited |